NICOLE MARSHALL: Open Payments
NPI 1912475328 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 28 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 3 | $60 |
| Aucta Pharmaceuticals, Inc. | 5 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| UCB, Inc. | 3 | $50 |
| ABBVIE INC. | 3 | $49 |
| Genentech USA, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| SK Life Science, Inc. | 1 | $20 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
Products named: Hizentra, Motpoly XR, AUSTEDO XR, Ocrevus Zunovo, INGREZZA, Briviact, QULIPTA, INBRIJA.
Industry payments across NJ — which companies pay providers there.
